Literature DB >> 26417951

Complications after Radiofrequency Ablation of 233 Hepatic Tumors.

Alexandre Zanchenko Fonseca1, William Abrao Saad, Marcelo Augusto Ribeiro.   

Abstract

OBJECTIVE: The only curative treatment for primary and secondary hepatic malignancies is surgery and liver transplantation. Thus, the majority of the patients are not candidates for resection, and there is a lack of organs. For these reasons, alternative treatment modalities such as radiofrequency ablation (RFA) are employed. The objective of this paper is to evaluate the incidence and types of complications related to open and percutaneous RFA.
METHOD: This is a retrospective study of patients with hepatic malignancies treated by RFA. Tumor size, location, numbers of nodules, approach, histology and associated procedures were analyzed and correlated to complications.
RESULTS: A total of 151 patients with primary and secondary hepatic malignancies were included: 58 with hepatocellular carcinoma (HCC), 68 with metastases from colorectal cancer and 25 with other types of tumors. Complications occurred in 24.5% of the patients, mostly (58.9%) in those with HCC. Ascites was the most common complication, followed by wound infection. The only two significant factors associated with complications were the presence of HCC (p = 0.0087) and two or more lesions (p = 0.0323). The mortality rate was 0.69%.
CONCLUSION: RFA is a safe technique, but complications may occur and are multifactorial. Appropriate patient selection, early complication recognition and adequate treatment are essential.
© 2015 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2015        PMID: 26417951     DOI: 10.1159/000439089

Source DB:  PubMed          Journal:  Oncology        ISSN: 0030-2414            Impact factor:   2.935


  3 in total

1.  Percutaneous Irreversible Electroporation: Long-term survival analysis of 71 patients with inoperable malignant hepatic tumors.

Authors:  C Niessen; S Thumann; L Beyer; B Pregler; J Kramer; S Lang; A Teufel; E M Jung; C Stroszczynski; P Wiggermann
Journal:  Sci Rep       Date:  2017-03-07       Impact factor: 4.379

2.  Comparison of radiofrequency ablation alone & in combination with percutaneous ethanol injection for management of hepatocellular carcinoma.

Authors:  Naveen Kalra; Mandeep Kang; Ajay K Duseja; Anmol Bhatia; Virendra Singh; Radha K Dhiman; Arvind Rajwanshi; Yogesh K Chawla; Niranjan Khandelwal
Journal:  Indian J Med Res       Date:  2017-11       Impact factor: 2.375

3.  Biopsy and Margins Optimize Outcomes after Thermal Ablation of Colorectal Liver Metastases.

Authors:  Nikiforos Vasiniotis Kamarinos; Efsevia Vakiani; Mithat Gonen; Nancy E Kemeny; Carlie Sigel; Leonard B Saltz; Karen T Brown; Anne M Covey; Joseph P Erinjeri; Lynn A Brody; Etay Ziv; Hooman Yarmohammadi; Henry Kunin; Afsar Barlas; Elena N Petre; Peter T Kingham; Michael I D'Angelica; Katia Manova-Todorova; Stephen B Solomon; Constantinos T Sofocleous
Journal:  Cancers (Basel)       Date:  2022-01-29       Impact factor: 6.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.